Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-048210
Filing Date
2019-09-04
Accepted
2019-09-04 16:34:55
Documents
1
Period of Report
2019-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4362
  Complete submission text file 0001209191-19-048210.txt   5861
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

EIN.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHARMACYCLICS, INC 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Tomasello Shawn (Reporting) CIK: 0001617239 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38653 | Film No.: 191075021